AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 171 min read$MLAB

Kadia Siddhartha purchased $800K of MLAB (indirect holdings)

Kadia Siddhartha (President and CEO) purchased 7,093 indirectly-held shares of MESA LABORATORIES INC /CO/ (MLAB) at $112.80 ($0.80M total) on 2026-08-13.

Original reporting
SEC EDGAR · Kadia Siddhartha
Published Aug 17, 2026, 3:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 4:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$MLAB
Neutral
medium confidence
Mentioned
$MLAB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MLABNeutralLow
01

Why it matters

A CEO open-market purchase of $800,090.40 is a sentiment signal, but the filing contains no new company performance, guidance, or deal information.

02

Market read

Traders may note the insider buy as a mild positive sentiment datapoint, but it is unlikely to drive a major repricing without additional fundamentals.

03

What to watch

The filing does not state intent, funding source, or whether additional buys are planned; without 10b5-1 context, interpretation is less reliable.

Relevance 6/10Novelty 4/10Timing: filed 2026-08-17, transaction dated 2026-08-13

Background

The article is an SEC Form 4 insider transaction disclosure for Mesa Laboratories (MLAB).

Company-level read

Ticker impact

$MLABNeutralMedium confidence
Context

MLAB disclosed an open-market purchase by President and CEO Kadia Siddhartha for 7,093 shares at $112.80 on 2026-08-13.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any reaction should be muted.

Evidence & confidence

This is a single insider buy with no 10b5-1 plan and no accompanying company guidance, contract, or operational update in the text.

Market effects

Sector

No sector-wide implications are provided; this is company-specific insider activity.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider buys can be routine, tax-related, or opportunistic and may not reflect a change in business outlook.

Key entities

  • public_company
    MLAB

    Mesa Laboratories Inc /CO/; issuer of the Form 4 insider transaction.

  • insider
    Kadia Siddhartha

    President and CEO who reported an open-market purchase of 7,093 shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

MLAB insider trading history →

Related articles

OCT 13
$MLABMedAI 8/10

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million…

MESA LABORATORIES INC /CO/ (MLAB) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth The Restructuring Program focuses Clinical Genomics on profitability and adds resources in

SEC EDGAR 8-K6 min
AUG 17
$MLABMedAI 8/10

Mesa Laboratories (MLAB) Q1 2027 Earnings Call Transcript

Mesa Laboratories (MLAB) reported Q1 FY2027 revenues of $60.1 million, up 1% year over year, with core organic growth of 0.4%. Adjusted operating income was $15.4 million, up 19.5%, and gross margin rose to 64.9%. Net leverage fell to 1.85x after $8.7 million debt repayment. SDC revenue was $24.5 million, down 3.6% organically.

fool.com6 min
AUG 10
$MLABMed

Mesa Labs Announces First Quarter Results

MESA LABORATORIES INC /CO/ (MLAB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Mesa Labs Announces First Quarter Results Lakewood, Colorado , August 10, 2026 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announc

SEC EDGAR 8-K6 min
MAY 27
$MLABHighAI 9/10

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

Mesa Laboratories (NASDAQ:MLAB) reported 4Q26 revenues up 2.6% to $63.7M and FY26 revenues up 3.4% to $249.1M. Operating income rose 87% to $2.75M in 4Q26 and 13.3% to $18.5M in FY26. Non-GAAP AOI excluding unusual items increased 49.2% (4Q26) and 11.9% (FY26); FY26 free cash flow was $39.6M, used mainly to repay $14.7M debt, reducing net leverage to 2.11.

manilatimes.net3 min